World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
75
Citations
20921
World Ranking
1981
National Ranking
969

Arthur A. Vandenbark publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Arthur A. Vandenbark sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 377 publications — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Arthur A. Vandenbark D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Arthur A. Vandenbark sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 75 D-Index — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Arthur A. Vandenbark is affiliated with Oregon Health & Science University in the United States. Their research interests focus primarily on neuroscience and immunology, with extensive work in related subfields such as immunology, neurology, and cellular and molecular neuroscience.

Vandenbark's research encompasses several main study areas including:

  • Neuroscience
  • Immunology and Microbiology

Their subfields of study highlight a specialized focus on:

  • Immunology
  • Neurology
  • Cellular and Molecular Neuroscience
  • Molecular Biology
  • Developmental Neuroscience

Key topics of Vandenbark's work cover:

  • Macrophage Migration Inhibitory Factor
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Nuclear Receptors and Signaling
  • Neurological Disease Mechanisms and Treatments
  • Immune Response and Inflammation
  • Neurogenesis and neuroplasticity mechanisms
  • Immune cells in cancer

Several recent papers reflect their ongoing contributions in these fields, including:

  • Microglia and astrocyte involvement in neurodegeneration and brain cancer, 2021, Journal of Neuroinflammation
  • Sex differences in EAE reveal common and distinct cellular and molecular components, 2020, Cellular Immunology

Other notable publications where Vandenbark has related interest or coauthorship include:

  • Cross-Talk of the CNS With Immune Cells and Functions in Health and Disease, 2021, Frontiers in Neurology
  • MIF contribution to progressive brain diseases, 2024, Journal of Neuroinflammation
  • MIF and CD74 as Emerging Biomarkers for Immune Checkpoint Blockade Therapy, 2024, Cancers

Their collaborations include frequent co-authors such as:

  • Halina Offner
  • Roberto Meza-Romero
  • Jack Wiedrick
  • Mikah S. Brandes
  • Nora E. Gray

Vandenbark has published extensively in several scientific venues, with the highest number of their works appearing in:

  • Cellular Immunology
  • Metabolic Brain Disease
  • Journal of Neuroinflammation
  • Frontiers in Neurology
  • Cancers

Best Publications

  • Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis.

    Arthur A. Vandenbark;George Hashim;Halina Offner;Halina Offner

  • Experimental Stroke Induces Massive, Rapid Activation of the Peripheral Immune System:

    Halina Offner;Sandhya Subramanian;Susan M Parker;Michael E Afentoulis

  • Cutting Edge: Estrogen Drives Expansion of the CD4+CD25+ Regulatory T Cell Compartment

    Magdalena J. Polanczyk;Bryan D. Carson;Bryan D. Carson;Sandhya Subramanian;Michael Afentoulis

  • Splenic Atrophy in Experimental Stroke Is Accompanied by Increased Regulatory T Cells and Circulating Macrophages

    Halina Offner;Halina Offner;Sandhya Subramanian;Susan M. Parker;Chunhe Wang;Chunhe Wang

  • Decreased FOXP3 levels in multiple sclerosis patients.

    Jianya Huan;Nicole Culbertson;Nicole Culbertson;Leslie Spencer;Leslie Spencer;Richard Bartholomew

  • T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation.

    Patricia D. Hurn;Sandhya Subramanian;Susan M. Parker;Michael E. Afentoulis

  • Both rat and mouse T cell receptors specific for the encephalitogenic determinant of myelin basic protein use similar V alpha and V beta chain genes even though the major histocompatibility complex and encephalitogenic determinants being recognized are different.

    F. R. Burns;Xiaobin Li;Ning Shen;H. Offner

  • Low-Dose Estrogen Therapy Ameliorates Experimental Autoimmune Encephalomyelitis in Two Different Inbred Mouse Strains

    Bruce F. Bebo;Amber Fyfe-Johnson;Kirsten Adlard;Aaron G. Beam

  • Regulatory B cells limit CNS inflammation and neurologic deficits in murine experimental stroke

    Xuefang Ren;Kozaburo Akiyoshi;Suzan Dziennis;Suzan Dziennis;Arthur A. Vandenbark;Arthur A. Vandenbark

  • Androgens alter the cytokine profile and reduce encephalitogenicity of myelin-reactive T cells.

    Bruce F. Bebo;Jeanette C. Schuster;Arthur A. Vandenbark;Arthur A. Vandenbark;Halina Offner

  • Preferential T-cell receptor beta-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis.

    Brian L. Kotzin;Satyanarayana Karuturi;Yuan K. Chou;Joyce Lafferty

  • T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis.

    Halina Offner;George A. Hashim;Arthur A. Vandenbark

  • Treg suppressive activity involves estrogen-dependent expression of programmed death-1 (PD-1)

    Magdalena J. Polanczyk;Corwyn Hopke;Arthur A. Vandenbark;Arthur A. Vandenbark;Halina Offner;Halina Offner

  • Estrogen‐mediated immunomodulation involves reduced activation of effector T cells, potentiation of treg cells, and enhanced expression of the PD‐1 costimulatory pathway

    Magdalena J. Polanczyk;Corwyn Hopke;Arthur A. Vandenbark;Arthur A. Vandenbark;Halina Offner

  • Recombinant human β-galactoside binding lectin suppresses clinical and histological signs of experimental autoimmune encephalomyelitis

    Halina Offner;Bozena Celnik;Timothy S. Bringman;Denise Casentini-Borocz

  • GPR30 Contributes to Estrogen-Induced Thymic Atrophy

    Chunhe Wang;Babak Dehghani;Babak Dehghani;I. Jack Magrisso;I. Jack Magrisso;Elizabeth A. Rick

  • Functional assay for human CD4+CD25+ Treg cells reveals an age-dependent loss of suppressive activity.

    Laura Tsaknaridis;Leslie Spencer;Nicole Culbertson;Kevin Hicks

  • Treatment of multiple sclerosis with T-cell receptor peptides: results of a double-blind pilot trial.

    Arthur A. Vandenbark;Arthur A. Vandenbark;Yuan K. Chou;Ruth Whitham;Ruth Whitham;Michele Mass

  • Enhanced FoxP3 expression and Treg cell function in pregnant and estrogen-treated mice

    Magdalena J. Polanczyk;Magdalena J. Polanczyk;Corwyn Hopke;Jianya Huan;Arthur A. Vandenbark;Arthur A. Vandenbark

  • Effect of experimental stroke on peripheral immunity: CNS ischemia induces profound immunosuppression.

    H. Offner;A. A. Vandenbark;A. A. Vandenbark;Patricia D Hurn

  • Cutting Edge: Estrogen Drives Expansion of the CD4CD25 Regulatory T Cell Compartment 1

    Magdalena J. Polanczyk;Bryan D. Carson;Sandhya Subramanian;Michael Afentoulis

Frequent Co-Authors

Halina Offner
Halina Offner Oregon Health & Science University
Richard Bucala
Richard Bucala Yale University
Lars Fugger
Lars Fugger University of Oxford
Lin Leng
Lin Leng Yale University
Jef Raus
Jef Raus Hasselt University
Paco S. Herson
Paco S. Herson University of Colorado Denver
Yoram Reiter
Yoram Reiter Technion – Israel Institute of Technology
Charles K. Meshul
Charles K. Meshul Oregon Health & Science University
Deborah J. Anderson
Deborah J. Anderson Boston University
Cesar V. Borlongan
Cesar V. Borlongan University of South Florida

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare degrees can broaden career opportunities, especially in nursing and patient care roles. Many look for programs that balance quality with accessibility, such as those listed under accredited LPN programs easy to get into. These programs offer a streamlined path to entry-level nursing positions and valuable clinical experience.

Advancing beyond the LPN level, aspiring nurses often seek the easiest nurse practitioner program options. These programs are designed to accommodate busy schedules and provide the necessary training for advanced practice roles while maintaining academic rigor.

For those interested in mental health, becoming a Psychiatric Mental Health Nurse Practitioner (PMHNP) is a promising pathway. Programs highlighted as top PMHNP programs emphasize strong clinical placement rates, crucial for hands-on experience in psychiatric care settings.

Cost can be a major factor in program selection. Luckily, some cheapest online PMHNP programs offer affordable tuition without compromising on quality, making advanced psychiatric nursing education accessible to a broader range of students.

Best Scientists Citing Arthur A. Vandenbark

Trending Scientists

Recently Published Articles